These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Therapeutic plasma exchange for neuroimmunological disorders]. Shibuya N No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032 [No Abstract] [Full Text] [Related]
4. Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting. Hawke S; Matsuo H; Nicolle M; Malcherek G; Melms A; Willcox N Immunol Today; 1996 Jul; 17(7):307-11. PubMed ID: 8763815 [No Abstract] [Full Text] [Related]
5. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis. Xiao BG; Duan RS; Zhu WH; Lu CZ Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease. De Baets MH Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246 [TBL] [Abstract][Full Text] [Related]
7. Reduction of IgG levels in myasthenia. Nissenson AR N Engl J Med; 1977 Apr; 296(14):819-20. PubMed ID: 840285 [No Abstract] [Full Text] [Related]
8. [Treatment of generalized myasthenia using therapeutic plasmapheresis (review of the literature)]. Sapin SM; Marchuk AI; Golovteev VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(10):1574-9. PubMed ID: 3544616 [No Abstract] [Full Text] [Related]
9. Thymectomy: a potential therapeutic method for autoimmune diseases besides myasthenia gravis. Guo W; Zhao YP; Jiang YG; Fan SZ; Wang RW; Li ZP Med Hypotheses; 2008; 70(5):1072-3. PubMed ID: 18155855 [No Abstract] [Full Text] [Related]
11. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders. Katz J; Barohn RJ Phys Med Rehabil Clin N Am; 2001 May; 12(2):381-97. PubMed ID: 11345014 [TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis. Drachman DB N Engl J Med; 1994 Jun; 330(25):1797-810. PubMed ID: 8190158 [No Abstract] [Full Text] [Related]
13. Treatment and clinical research in myasthenia gravis: how far have we come? Barohn RJ Ann N Y Acad Sci; 2008; 1132():225-32. PubMed ID: 18567872 [TBL] [Abstract][Full Text] [Related]
15. Familial autoimmune myasthenia gravis. Tan JH; Ho KH Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320 [TBL] [Abstract][Full Text] [Related]
16. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome]. Andreis I; Lovnićki TJ; Beara N; Taradi M Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte activation in experimental autoimmune myasthenia gravis. De Baets MH; Einarson B; Lindstrom JM; Weigle WO J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589 [No Abstract] [Full Text] [Related]
18. Myasthenia gravis and premature ovarian failure. Ryan MM; Jones HR Muscle Nerve; 2004 Aug; 30(2):231-3. PubMed ID: 15266640 [TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis. Vincent A; Drachman DB Adv Neurol; 2002; 88():159-88. PubMed ID: 11908224 [No Abstract] [Full Text] [Related]
20. Thymectomy as treatment of autoimmune diseases other than myasthenia gravis. D'Andrea V; Malinovsky L; Ambrogi V; Artico M; Capuano LG; Buccolini F; De Antoni E Thymus; 1993 Feb; 21(1):1-10. PubMed ID: 8480342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]